These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 9399966)

  • 1. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.
    Martinez FD; Graves PE; Baldini M; Solomon S; Erickson R
    J Clin Invest; 1997 Dec; 100(12):3184-8. PubMed ID: 9399966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of β(2)-adrenergic receptor polymorphisms on asthma exacerbation in children with severe asthma regularly receiving salmeterol.
    Giubergia V; Gravina L; Castaños C; Chertkoff L
    Ann Allergy Asthma Immunol; 2013 Mar; 110(3):156-60. PubMed ID: 23548523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations.
    Carroll CL; Stoltz P; Schramm CM; Zucker AR
    Chest; 2009 May; 135(5):1186-1192. PubMed ID: 19029431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
    Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
    Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
    Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
    Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics.
    Tan S; Hall IP; Dewar J; Dow E; Lipworth B
    Lancet; 1997 Oct; 350(9083):995-9. PubMed ID: 9329515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
    Bleecker ER; Nelson HS; Kraft M; Corren J; Meyers DA; Yancey SW; Anderson WH; Emmett AH; Ortega HG
    Am J Respir Crit Care Med; 2010 Apr; 181(7):676-87. PubMed ID: 19910613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of beta2-adrenoceptor polymorphisms on the response to chronic use of albuterol in asthmatic children.
    Giubergia V; Gravina LP; Castaños C; Chertkoff L; Grenoville M
    Pediatr Pulmonol; 2008 May; 43(5):421-5. PubMed ID: 18383333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.
    Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN
    Am J Respir Crit Care Med; 2000 Jul; 162(1):75-80. PubMed ID: 10903223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.
    Lima JJ; Thomason DB; Mohamed MH; Eberle LV; Self TH; Johnson JA
    Clin Pharmacol Ther; 1999 May; 65(5):519-25. PubMed ID: 10340917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
    J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*.
    Kukreti R; Bhatnagar P; B-Rao C; Gupta S; Madan B; Das C; Guleria R; Athavale AU; Brahmachari SK; Ghosh B
    Pharmacogenomics; 2005 Jun; 6(4):399-410. PubMed ID: 16004558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
    Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A
    Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta2-adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics.
    Kotani Y; Nishimura Y; Maeda H; Yokoyama M
    J Asthma; 1999 Oct; 36(7):583-90. PubMed ID: 10524541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma.
    Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN;
    Int Arch Allergy Immunol; 2001; 124(1-3):183-6. PubMed ID: 11306963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.
    Israel E; Chinchilli VM; Ford JG; Boushey HA; Cherniack R; Craig TJ; Deykin A; Fagan JK; Fahy JV; Fish J; Kraft M; Kunselman SJ; Lazarus SC; Lemanske RF; Liggett SB; Martin RJ; Mitra N; Peters SP; Silverman E; Sorkness CA; Szefler SJ; Wechsler ME; Weiss ST; Drazen JM;
    Lancet; 2004 Oct 23-29; 364(9444):1505-12. PubMed ID: 15500895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
    Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
    Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma.
    Choudhry S; Ung N; Avila PC; Ziv E; Nazario S; Casal J; Torres A; Gorman JD; Salari K; Rodriguez-Santana JR; Toscano M; Sylvia JS; Alioto M; Castro RA; Salazar M; Gomez I; Fagan JK; Salas J; Clark S; Lilly C; Matallana H; Selman M; Chapela R; Sheppard D; Weiss ST; Ford JG; Boushey HA; Drazen JM; Rodriguez-Cintron W; Silverman EK; Burchard EG
    Am J Respir Crit Care Med; 2005 Mar; 171(6):563-70. PubMed ID: 15557128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma.
    Hancox RJ; Sears MR; Taylor DR
    Eur Respir J; 1998 Mar; 11(3):589-93. PubMed ID: 9596107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.